Byrne Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,000
| Closed | -$12.4K | – | 542 |
|
|
2023
Q4 | $12.4K | Hold |
8,000
| – | – | 0.01% | 336 |
|
|
2023
Q3 | $10K | Hold |
8,000
| – | – | 0.01% | 336 |
|
|
2023
Q2 | $14K | Buy |
8,000
+400
| +5% | +$700 | 0.01% | 368 |
|
|
2023
Q1 | $11K | Sell |
7,600
-6,500
| -46% | -$9.41K | 0.01% | 375 |
|
|
2022
Q4 | $22.6K | Buy |
+14,100
| New | +$22.6K | 0.02% | 309 |
|